Patents by Inventor Alwin Reiter

Alwin Reiter has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250027067
    Abstract: The present invention relates to fusion proteins of ACE2 with IgG Fc and the medical use of these fusion proteins, in particular in the prevention or treatment of infections with coronaviruses such as SARS-CoV-2, as well as methods of producing them.
    Type: Application
    Filed: November 24, 2022
    Publication date: January 23, 2025
    Applicant: Formycon AG
    Inventors: Alwin REITER, Carsten BROCKMEYER, Florian WOLSCHIN
  • Publication number: 20240139296
    Abstract: The present invention relates to pharmaceutical compositions of ACE2 Fc fusion proteins and therapeutic uses thereof, in particular in the treatment of infections with SARS-CoV-2.
    Type: Application
    Filed: March 3, 2022
    Publication date: May 2, 2024
    Applicant: Formycon AG
    Inventors: Alwin REITER, Rainer SIGL
  • Publication number: 20240018499
    Abstract: The present invention relates to fusion proteins of ACE2 with IgG Fc and the medical use of these fusion proteins, in particular in the prevention or treatment of infections with coronaviruses such as SARS-CoV-2.
    Type: Application
    Filed: October 29, 2021
    Publication date: January 18, 2024
    Inventors: Alwin Reiter, Carsten Brockmeyer, Florian Wolschin
  • Publication number: 20210363512
    Abstract: The present invention relates to fusion proteins of ACE2 with IgG Fc and the medical use of these fusion proteins, in particular in the prevention or treatment of infections with coronaviruses such as SARS-CoV-2.
    Type: Application
    Filed: May 21, 2021
    Publication date: November 25, 2021
    Inventors: Alwin Reiter, Carsten Brockmeyer, Florian Wolschin